Sree Chitra develops intravenous cancer drug

Kochi | Sunday | 24th March, 2019

Summary:

“And, we successfully conjugated the chemical drug to albumin, a natural drug-carrier in human blood with therapeutic applications,” Dr Krishnan said.Dr Krishnan and her team started research in 2010. “As it’s a cytotoxic drug, we need to get the right kind of concentration for multiple dosage therapy. Many universities and research institutes often prove in labs the anticancer properties of chemicals derived from plants and publish papers. Though we have found it safe in animals, a few more studies have to be done to get regulatory approvals for trial in human beings. It will take one to two years for this timeconsuming testing,” she added..